Mengbin H. Li

127 West Changle Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Progress in the development and application of disease-specific databases related to eye diseases

Progress in the development and application of disease-specific databases related to eye diseases

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: May 08, 2026

Impact of Diet and Drugs on Fecal Lachnoclostridium Gene Marker (m3) in Non-Invasive Diagnosis of Colorectal Neoplasia.

Impact of Diet and Drugs on Fecal Lachnoclostridium Gene Marker (m3) in Non-Invasive Diagnosis of Colorectal Neoplasia.

Journal: Journal of gastroenterology and hepatology

Published: September 01, 2025

Discovery and characterization of Christensenella hongkongensis as a novel bacterium in the adenoma-carcinoma progression.

Discovery and characterization of Christensenella hongkongensis as a novel bacterium in the adenoma-carcinoma progression.

Journal: Journal of translational medicine

Published: August 22, 2025

Early versus late supplemental parenteral nutrition in gastrointestinal cancer patients undergoing major abdominal surgery: 5-year outcomes from a randomized clinical trial.

Early versus late supplemental parenteral nutrition in gastrointestinal cancer patients undergoing major abdominal surgery: 5-year outcomes from a randomized clinical trial.

Journal: International journal of surgery (London, England)

Published: June 10, 2025

Novel fecal microbial biomarkers for noninvasive diagnosis of colorectal cancer and advanced adenomas: A prospective multicenter cohort study.

Novel fecal microbial biomarkers for noninvasive diagnosis of colorectal cancer and advanced adenomas: A prospective multicenter cohort study.

Journal: Chinese medical journal

Published: June 03, 2025

Main results of a randomized controlled trial (RNPLS-01): efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant therapy for advanced gastric cancer.

Main results of a randomized controlled trial (RNPLS-01): efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant therapy for advanced gastric cancer.

Journal: International journal of surgery (London, England)

Published: April 11, 2025

Clinical features of CHARGE syndrome in children

Clinical features of CHARGE syndrome in children

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: March 06, 2025

Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study.

Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: February 26, 2025

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.

Journal: Cancer biology & therapy

Published: June 12, 2024

Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01).

Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01).

Journal: Heliyon

Published: January 21, 2024

Gastric residual volume, safety, and effectiveness of drinking 250 mL of glucose solution 2-3 hours before surgery in gastric cancer patients: a multicenter, single-blind, randomized-controlled trial.

Gastric residual volume, safety, and effectiveness of drinking 250 mL of glucose solution 2-3 hours before surgery in gastric cancer patients: a multicenter, single-blind, randomized-controlled trial.

Journal: Gastroenterology report

Published: December 18, 2023

Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study.

Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study.

Journal: Frontiers in oncology

Published: November 01, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026